Gene · 10257
Papers3,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dietary protein intake and the tubular handling of indoxyl sulfate. | Nephrol Dial Transplant | 2025 | 39354683 | PubTator, text mining | PubMed |
| Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells. | Anticancer Agents Med Chem | 2025 | 39219427 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Effect of hypoxia on aquaporins and hepatobiliary transport systems in human hepatic cells. | Pediatr Res | 2025 | 38951656 | PubTator, text mining | PubMed |
| A generalizable Hi-C foundation model for chromatin architecture, single-cell and multi-omics analysis across species. | bioRxiv | 2024 | 39763871 | PubTator, text mining | PubMed |
| Reimagining the meninges from a neuroimmune perspective: a boundary, but not peripheral. | J Neuroinflammation | 2024 | 39548515 | PubTator, text mining | PubMed |
| Febuxostat-induced agranulocytosis in a pediatric hematopoietic stem cell transplant recipient: Case Report and literature review. | Front Pharmacol | 2024 | 39508043 | PubTator, text mining | PubMed |
| Circular RNA circABCC4 as the ceRNA facilitates renal carcinoma progression. | World J Urol | 2024 | 39475972 | PubTator, text mining | PubMed |
| Enhanced platelet sensitization is accompanied by increased expression of the transporter MRP4 and elevated plasma S1P levels in mild COVID-19 convalescents. | Platelets | 2024 | 39475058 | PubTator, text mining | PubMed |
| Obesity-related drug transporter expression alterations in human liver and kidneys. | Pharmacol Rep | 2024 | 39412582 | PubTator, text mining | PubMed |
| Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. | Int J Biol Macromol | 2024 | 39378921 | PubTator, text mining | PubMed |
| Differential Selectivity of Human and Mouse ABCC4/Abcc4 for Arsenic Metabolites. | Drug Metab Dispos | 2024 | 39313329 | PubTator, text mining | PubMed |
| Organic anion transporters in remote sensing and organ crosstalk. | Pharmacol Ther | 2024 | 39284369 | PubTator, text mining | PubMed |
| Tumor ABCC4-mediated release of PGE2 induces CD8+ T cell dysfunction and impairs PD-1 blockade in prostate cancer. | Int J Biol Sci | 2024 | 39247809 | PubTator, text mining | PubMed |
| Studies on absorption mechanism and pharmacokinetic properties of albendazole-bile acid conjugate: In vivo and in vitro. | Biomed Pharmacother | 2024 | 39243427 | PubTator, text mining | PubMed |
| The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects. | Int J Mol Sci | 2024 | 39201768 | PubTator, text mining | PubMed |
| Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. | Rheumatology (Oxford) | 2024 | 39137147 | PubTator, text mining | PubMed |
| The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. | Front Pharmacol | 2024 | 39114357 | PubTator, text mining | PubMed |
| Overcoming flumatinib resistance in chronic myeloid leukaemia: Insights into cellular mechanisms and ivermectin's therapeutic potential. | J Cell Mol Med | 2024 | 39046364 | PubTator, text mining | PubMed |
| Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4. | Clin Pharmacol Ther | 2024 | 39039844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10257/papers?page=6